These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 39075533)

  • 1. Exploring the relationship between condition severity and health-related quality of life in people with haemophilia A across Europe: a multivariable analysis of data from the CHESS II study.
    Ferri Grazzi E; Hawes C; Camp C; Hinds D; O'Hara J; Burke T
    Health Qual Life Outcomes; 2024 Jul; 22(1):58. PubMed ID: 39075533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and Humanistic Burden of Non-inhibitor Haemophilia A in Five European Countries: Insights from the CHESS II Study.
    Ferri Grazzi E; Becker T; Brandt S; Duport G; Garcia Diego DA; Lupi A; McKeown W; Morgan D; Camp C; Hawes C; Blenkiron T; O'Hara J; Burke T
    Adv Ther; 2024 Oct; 41(10):3888-3904. PubMed ID: 39153051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of severe haemophilia and the presence of target joints on health-related quality-of-life.
    O'Hara J; Walsh S; Camp C; Mazza G; Carroll L; Hoxer C; Wilkinson L
    Health Qual Life Outcomes; 2018 May; 16(1):84. PubMed ID: 29720192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-world comparative analysis of bleeding complications and health-related quality of life in patients with haemophilia A and haemophilia B.
    Booth J; Oladapo A; Walsh S; O'Hara J; Carroll L; Garcia Diego DA; O'Mahony B
    Haemophilia; 2018 Sep; 24(5):e322-e327. PubMed ID: 30091822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of bleeding event frequency on health-related quality of life and work productivity outcomes in a European cohort of adults with haemophilia A: insights from the CHESS II study.
    Young L; Chen Y; Alvir J; Burke T; Ferri Grazzi E; Winburn I
    Orphanet J Rare Dis; 2023 Aug; 18(1):227. PubMed ID: 37537683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease Burden, Clinical Outcomes, and Quality of Life in People with Hemophilia A without Inhibitors in Europe: Analyses from CHESS II/CHESS PAEDs.
    Chowdary P; Ofori-Asenso R; Nissen F; Grazzi EF; Aizenas M; Moreno K; Burke T; Nolan B; O'Hara J; Khair K
    TH Open; 2024 Apr; 8(2):e181-e193. PubMed ID: 38628421
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical, humanistic, and economic burden of severe haemophilia B in adults receiving factor IX prophylaxis: findings from the CHESS II real-world burden of illness study in Europe.
    Burke T; Asghar S; O'Hara J; Chuang M; Sawyer EK; Li N
    Orphanet J Rare Dis; 2021 Dec; 16(1):521. PubMed ID: 34930388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life, direct medical and societal costs among children with moderate or severe haemophilia in Europe: multivariable models of the CHESS-PAEDs study.
    Rodriguez-Santana I; DasMahapatra P; Burke T; Hakimi Z; Bartelt-Hofer J; Nazir J; O'Hara J
    Orphanet J Rare Dis; 2022 Apr; 17(1):150. PubMed ID: 35379284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Social/economic costs and quality of life in patients with haemophilia in Europe.
    Cavazza M; Kodra Y; Armeni P; De Santis M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Gulácsi L; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1():53-65. PubMed ID: 27048374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxiety and depression among adults with haemophilia A: Patient and physician reported symptoms from the real-world European CHESS II study.
    Ferri Grazzi E; Blenkiron T; Hawes C; Camp C; O'Hara J; Burke T; O'Brien G
    Haemophilia; 2024 May; 30(3):743-751. PubMed ID: 38507035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of factor expression levels with health-related quality of life and direct medical costs for people with haemophilia B.
    Burke T; Shaikh A; Ali TM; Li N; Curtis R; Garcia Diego DA; Recht M; Sannie T; Skinner M; O'Hara J
    J Med Econ; 2022; 25(1):386-392. PubMed ID: 35253589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic and Humanistic Burden of Moderate and Severe Hemophilia A and B in Spain: Real-World Evidence Insights from the CHESS II Study.
    Peral C; De Lossada Juste A; Lwoff N; Espinoza-Cámac N; Casado MÁ; Burke T; Alvir J; Thakkar S; Ferri Grazzi E
    J Health Econ Outcomes Res; 2024; 11(1):122-133. PubMed ID: 38721331
    [No Abstract]   [Full Text] [Related]  

  • 13. The societal burden of haemophilia A. I - A snapshot of haemophilia A in Australia and beyond.
    Brown LJ; La HA; Li J; Brunner M; Snoke M; Kerr AM
    Haemophilia; 2020 Aug; 26 Suppl 5():3-10. PubMed ID: 32935397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No difference in quality of life between persons with severe haemophilia A and B.
    Kihlberg K; Baghaei F; Bruzelius M; Funding E; Andre Holme P; Lassila R; Nummi V; Ranta S; Gretenkort Andersson N; Berntorp E; Astermark J
    Haemophilia; 2023 Jul; 29(4):987-996. PubMed ID: 36791275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humanistic burden of problem joints for children and adults with haemophilia.
    Burke T; Rodriguez-Santana I; Chowdary P; Curtis R; Khair K; Laffan M; Mclaughlin P; Noone D; O'Mahony B; Pasi J; Skinner M; O'Hara J
    Haemophilia; 2023 Mar; 29(2):608-618. PubMed ID: 36574369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The humanistic and economic burden of problem joints for children and adults with moderate or severe haemophilia A: Analysis of the CHESS population studies.
    Chowdary P; Nissen F; Burke T; Aizenas M; Czirok T; Dhillon H; O'Hara J
    Haemophilia; 2023 May; 29(3):753-760. PubMed ID: 36897517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life and health status in adolescent and adult people with haemophilia A without factor VIII inhibitors-A non-interventional study.
    Oldenburg J; Tran H; Peyvandi F; Núñez R; Trask P; Chebon S; Mahlangu JN; Lehle M; Jiménez-Yuste V; von Mackensen S
    Haemophilia; 2021 May; 27(3):398-407. PubMed ID: 33576546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life and health status in persons with haemophilia A with inhibitors: A prospective, multicentre, non-interventional study (NIS).
    Mahlangu J; Oldenburg J; Callaghan MU; Shima M; Mancuso ME; Trask P; Recht M; Garcia C; Yang R; Lehle M; Macharia H; Asikanius E; Levy GG; Kruse-Jarres R; von Mackensen S
    Haemophilia; 2019 May; 25(3):382-391. PubMed ID: 31016855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential humanistic and economic burden of mild, moderate and severe haemophilia in european adults: a regression analysis of the CHESS II study.
    Rodriguez-Santana I; DasMahapatra P; Burke T; Hakimi Z; Bartelt-Hofer J; Nazir J; O'Hara J
    Orphanet J Rare Dis; 2022 Apr; 17(1):148. PubMed ID: 35379282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of joint health in patients receiving prophylaxis for haemophilia A: a cross-sectional survey in five European countries.
    De la Corte-Rodríguez H; Bystrická L; Ball N; Olsen S; Golden K; Hakimi Z; Kragh N
    BMJ Open; 2024 Sep; 14(9):e082204. PubMed ID: 39260833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.